HSP90AA1 is a carcinogenic enhancer in ESCC, and inhibition of its activity significantly weakens cell proliferation and induces cell apoptosis, with a lower HSP90AA1 expression predicting a better prognosis of ESCC (Ye et al., 2021). This evidence concerns the gene HSP90AA1 and esophageal squamous cell carcinoma.